SURUNKALI BUYRAK KASALLIGI BO‘LGAN COVID-19 INFEKSIYASINI O‘TKAZGAN BEMORLARDA LIPID SPEKTORI KO‘RSATKICHLARINING TAHLILI
Kalit so'zlar
https://doi.org/10.47390/Med-pro/v3i6y2025/N04Kalit so'zlar
COVID-19, lipid spektori, koronavirus infeksiyasi, YuZLP, TGL, PZLPAnnotasiya
SBK kechishida asosiy metabolik omillardan biri giperlipidemiya hisoblanadi. Koronavirus infeksiyasi tufayli o‘lim ko‘rsatkichi yuqori bo‘lgan odamlarning aksariyati semizlik, qandli diabet va boshqa metobolik kasalliklar bilan aziyat chekishgan. Ko‘plab tadqiqotlarda COVID-19 infeksiyasi bilan og‘rigan bemorlarda YuZLP ning kamayishi, TGL va PZLP darajasining ortishi kuzatilgan
Manbalar
1. Арутюнов Г. П., Тарловская Ye. И., Арутюнов А. Г. и др. Вновь диагностированные заболевания и частота их возникновения у пациентов после новой коронавирусной инфекции. Результаты международного регистра "Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2)" (12 месяцев наблюдения). Российский кардиологический журнал. 2023;28(4):5424. https://doi.org/10.15829/1560-4071-2023-5424
2. Płazak W, Drabik L. SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis. Clin Rheumatol. 2023:112. https://doi.org/10.1007/ s10067-022-06497-1.
3. Арутюнов Г. П., Тарловская Е. И., Арутюнов А. Г. и др. Анализ показателей липидного спектра у госпитализированных пациентов с COVID-19 в зависимости от исхода острого периода инфекции по данным международного регистра "Анализ динамики Коморбидных заболеваний у пациенТов, перенесшИх инфицироВание SARS-CoV-2". Российский кардиологический журнал. 2022;27(9):5042. https://doi.org/10.15829/1560-4071-2022-5042
4. Fan J, Wang H, Ye G, et al. Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism. 2020;107:154243. https://doi.org/10.1016/j.metabol.2020.154243
5. Hu X, Chen D, Wu L, et al. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020;510:105-10. https://doi.org/10.1016/j.cca.2020.07.015
6. Wei X, Zeng W, Su J, et al. Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020;14(3):297-304. https://doi.org/10.1016/j.jacl.2020.04.008
7. Fernández-Friera L, Fuster V, López-Melgar B, et al. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. J Am Coll Cardiol. 2017;70(24):297991. https://doi.org/10.1016/j.jacc.2017.10.024
8. Lee H, Ahn HJ, Park HE, et al. The effect of non-optimal lipids on the progression of coronary artery calcification in statin-naïve young adults: results from KOICA registry. Front Cardiovasc Med. 2023;10:1173289. https://doi.org/10.3389/fcvm.2023.1173289
9. Brunner FJ, Waldeyer C, Ojeda F, et al. Multinational Cardiovascular Risk Consortium. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet. 2019;394(10215):2173-83. https://doi.org/10.1016/S0140-6736(19)32519-X
10. He X, Liu C, Peng J, et al. COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors. Signal Transduct. Target. Ther. 2021;6:427. https://doi.org/10.1038/s41392-021-00822-x.
11. Bizkarguenaga M, Bruzzone C, Gil-Redondo R, et al. Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics. NMR Biomed. 2022;35:e4637. https://doi.org/10.1002/nbm.4637 .
12. Washirasaksiri C, Sayabovorn N, Ariyakunaphan P, et al. Long-term multiple metabolic abnormalities among healthy and high-risk people following nonsevere COVID-19. Sci Rep. 2023;13(1):14336. https://doi.org/10.1038/s41598-023-41523-5